发明名称 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
摘要 The present invention relates to a method for inhibiting the etiology of disease in patients having a disease state caused by an excess of 12-lipoxygenase or its products. In particular, the invention provides for administration of a human leukocyte 12-lipoxygenase pathway inhibitor to inhibit disease etiology, to inhibit the proliferation of breast cancer and to increase insulin receptor phosphorylation in a patient having Type II diabetics.
申请公布号 US6191169(B1) 申请公布日期 2001.02.20
申请号 US19970945744 申请日期 1997.11.03
申请人 CITY OF HOPE 发明人 NADLER JERRY L.;NATARAJAN RAMA
分类号 A61K31/00;A61K31/045;A61K31/05;A61K31/155;A61K31/195;A61K31/20;A61K31/35;A61K31/352;A61K31/44;A61K31/4439;A61K31/575;A61K38/00;A61K38/08;A61K38/18;A61K38/20;A61K38/43;C12N9/02;C12N15/113;C12Q1/26;G01N33/573;G01N33/68;(IPC1-7):A61K31/195 主分类号 A61K31/00
代理机构 代理人
主权项
地址